Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NU-1064 and NU-1076, PARP inhibitors

April 19, 1996

Dipyridamole analogue more potent than parent drug

April 19, 1996

Cancer Research Center, Moscow, presents MDR inhibitors at NCI-EORTC

April 19, 1996

ONYX-015 enters clinical testing

April 19, 1996

Japanese scientists present antitumor agents

April 19, 1996

Peptech neuropeptide antagonists in clinical studies

April 19, 1996

Taisho claims antitumor steroids

April 19, 1996

Agouron continues to discover MMP inhibitors

April 19, 1996

PD-154309 revealed at 211th ACS

April 19, 1996

AntiCancer, Celltech present gelatinase A inhibitor at NCI-EORTC

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...